Trials & R&D · 16h ago STAT+: Why Gilead can’t stop talking about its ambitions in immunology 1 outlet Gilead Sciences
Pricing & policy · yesterday Gilead: HIV Growth Is Not Enough At The Current Price 1 outlet Gilead Sciences